Martin Ho1, Anindita Saha1, K Kimberly McCleary2, Bennett Levitan3, Stephanie Christopher4, Kristen Zandlo5, R Scott Braithwaite6, A Brett Hauber7. 1. Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, USA. 2. FasterCures, Milken Institute, Washington, DC, USA. 3. Janssen Research and Development, LLC, Titusville, NJ, USA. 4. Medical Device Innovation Consortium, Minneapolis, MN, USA. Electronic address: schristopher@mdic.org. 5. Medical Device Innovation Consortium, Minneapolis, MN, USA. 6. Department of Population Health, NYU School of Medicine, New York, NY, USA. 7. RTI Health Solutions, Research Triangle Park, NC, USA.
Abstract
BACKGROUND: In response to 2012 guidance in which the US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) stated the importance of patient-centric measures in regulatory benefit-risk assessments, the Medical Device Innovation Consortium (MDIC) initiated a project. The project was used to develop a framework to help the Food and Drug Administration (FDA) and industry sponsors understand how patient preferences regarding benefit and risk might be integrated into the review of innovative medical devices. METHODS: A public-private partnership of experts from medical device industry, government, academia and non-profits collaborated on development of the MDIC patient centered benefit-risk framework. RESULTS: The MDIC Framework examines what patient preference information is and the potential use and value of patient preference information in the regulatory process and across the product development life cycle. The MDIC Framework also includes a catalog of patient preference assessment methods and an agenda for future research to advance the field. CONCLUSIONS: This article discusses key concepts in patient preference assessment of particular importance for regulators and researchers that are addressed in the MDIC Framework for patient centered benefit-risk assessment as well as the unique public-private collaboration that led its development.
BACKGROUND: In response to 2012 guidance in which the US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) stated the importance of patient-centric measures in regulatory benefit-risk assessments, the Medical Device Innovation Consortium (MDIC) initiated a project. The project was used to develop a framework to help the Food and Drug Administration (FDA) and industry sponsors understand how patient preferences regarding benefit and risk might be integrated into the review of innovative medical devices. METHODS: A public-private partnership of experts from medical device industry, government, academia and non-profits collaborated on development of the MDIC patient centered benefit-risk framework. RESULTS: The MDIC Framework examines what patient preference information is and the potential use and value of patient preference information in the regulatory process and across the product development life cycle. The MDIC Framework also includes a catalog of patient preference assessment methods and an agenda for future research to advance the field. CONCLUSIONS: This article discusses key concepts in patient preference assessment of particular importance for regulators and researchers that are addressed in the MDIC Framework for patient centered benefit-risk assessment as well as the unique public-private collaboration that led its development.
Authors: V Valentí; J Ramos; C Pérez; L Capdevila; I Ruiz; L Tikhomirova; M Sánchez; I Juez; M Llobera; E Sopena; J Rubió; R Salazar Journal: Clin Transl Oncol Date: 2019-09-26 Impact factor: 3.405
Authors: Heather L Benz; Ting-Hsuan Joyce Lee; Jui-Hua Tsai; John F P Bridges; Sara Eggers; Megan Moncur; Fadia T Shaya; Ira Shoulson; Erica S Spatz; Leslie Wilson; Anindita Saha Journal: Patient Date: 2019-12 Impact factor: 3.883
Authors: Jennifer E Flythe; Derek Forfang; Nieltje Gedney; David M White; Caroline Wilkie; Kerri L Cavanaugh; Raymond C Harris; Mark Unruh; Grace Squillaci; Melissa West; Carol Mansfield; Cindy S Soloe; Katherine Treiman; Dallas Wood; Frank P Hurst; Carolyn Y Neuland; Anindita Saha; Murray Sheldon; Michelle E Tarver Journal: Kidney360 Date: 2022-05-05
Authors: Bethea A Kleykamp; Robert H Dworkin; Dennis C Turk; Zubin Bhagwagar; Penney Cowan; Christopher Eccleston; Susan S Ellenberg; Scott R Evans; John T Farrar; Roy L Freeman; Louis P Garrison; Jennifer S Gewandter; Veeraindar Goli; Smriti Iyengar; Alejandro R Jadad; Mark P Jensen; Roderick Junor; Nathaniel P Katz; J Patrick Kesslak; Ernest A Kopecky; Dmitri Lissin; John D Markman; Michael P McDermott; Philip J Mease; Alec B O'Connor; Kushang V Patel; Srinivasa N Raja; Michael C Rowbotham; Cristina Sampaio; Jasvinder A Singh; Ilona Steigerwald; Vibeke Strand; Leslie A Tive; Jeffrey Tobias; Ajay D Wasan; Hilary D Wilson Journal: Pain Date: 2021-09-09 Impact factor: 7.926